A Systematic Review Comparing Surveillance Recommendations for the Detection of Recurrence Following Surgery Across 16 Common Cancer Types
BMJ oncology(2025)
Department of Public Health and Primary Care | School of Clinical Medicine | Department of Oncology | Department of Surgery | Independent Researcher. | Department of Urology | Department of Thoracic Oncology | Hepato-Pancreato-Bilary Surgery | Precision Breast Cancer Institute
Abstract
Objectives Identify and compare guidelines making recommendations for surveillance to detect recurrence in 16 common solid cancers after initial curative treatment in asymptomatic patients.Methods and analysis We conducted a systematic review, combining search results from two electronic databases, one guideline organisation website (NICE), expert consultation and manual searching. Screening and data extraction were carried out by multiple reviewers. We collected data from each guideline on recommendations for surveillance and the use of risk stratification. Findings were compared between cancer types and regions. Text mining was used to extract statements on the evidence for surveillance. A protocol was published on PROSPERO in 2021 (CRD42021289625).Results We identified 123 guidelines across 16 cancer types. Almost all guidelines (n=115, 93.5%) recommend routine surveillance for recurrent disease in asymptomatic patients after initial treatment. Around half (n=59, 51.3%) recommend indefinite or lifelong surveillance. The most common modality of surveillance was cross-sectional imaging. Risk stratification of frequency, length and mode of surveillance was widespread, with most guidelines (n=92, 74.8%) recommending that surveillance be adapted based on patient risk. More than a third (n=50, 39.0%) gave incomplete or vague recommendations. For 14 cancers, we found statements indicating there is no evidence that surveillance improves survival.Conclusion Although specific details of follow-up schedules vary, common challenges were identified across cancer types. These include heterogenous recommendations, vague or non-specific guidance and a lack of cited evidence supporting the use of surveillance to improve outcomes. Evidence generation in this area is challenging; however, increased availability to linked health records may provide a way forward.PROSPERO registration number CRD42021289625.
MoreTranslated text
求助PDF
上传PDF
View via Publisher
AI Read Science
AI Summary
AI Summary is the key point extracted automatically understanding the full text of the paper, including the background, methods, results, conclusions, icons and other key content, so that you can get the outline of the paper at a glance.
Example
Background
Key content
Introduction
Methods
Results
Related work
Fund
Key content
- Pretraining has recently greatly promoted the development of natural language processing (NLP)
- We show that M6 outperforms the baselines in multimodal downstream tasks, and the large M6 with 10 parameters can reach a better performance
- We propose a method called M6 that is able to process information of multiple modalities and perform both single-modal and cross-modal understanding and generation
- The model is scaled to large model with 10 billion parameters with sophisticated deployment, and the 10 -parameter M6-large is the largest pretrained model in Chinese
- Experimental results show that our proposed M6 outperforms the baseline in a number of downstream tasks concerning both single modality and multiple modalities We will continue the pretraining of extremely large models by increasing data to explore the limit of its performance
Upload PDF to Generate Summary
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
Chat Paper